Treatment of haemophilia.
D004470:Economics, Medical; D005164:Factor IX / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005169:Factor VIII / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006395:Hemarthrosis / Q000139:chemically induced; D006467:Hemophilia A / Q000188:drug therapy*; D006487:Hemostasis; D006801:Humans; D009133:Muscular Atrophy / Q000517:prevention & control; D026741:Physical Therapy Modalities; D013165:Splints
D005169:Factor VIII; D005164:Factor IX